Doximity (NYSE: DOCS) revenue
Doximity reported revenue of $644.9m for fiscal 2026, 13.1% more than in fiscal 2025 ($570.4m). Since fiscal 2021 its revenue has grown by 211.7%, an average growth of 25.5% a year.
Doximity has grown its revenue for 5 years in a row, and fiscal 2026 is the highest of its 6 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $644.9m | +13.1% | $214.9m | 33.3% |
| 2025 | $570.4m | +20.0% | $227.8m | 39.9% |
| 2024 | $475.4m | +13.5% | $163.9m | 34.5% |
| 2023 | $419.1m | +22.0% | $125.1m | 29.9% |
| 2022 | $343.5m | +66.0% | $113.5m | 33.0% |
| 2021 | $206.9m | — | $53.3m | 25.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Doximity revenue compared with its sector
By revenue for its latest fiscal year, Doximity ranks 179th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Doximity, 13.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 177th | Kiniksa Pharmaceuticals International | $677.6m | 60.1% |
| 178th | Ultragenyx Pharmaceutical | $673.0m | 20.2% |
| 179th | Doximity | $644.9m | 13.1% |
| 180th | 10x Genomics | $642.8m | 5.2% |
| 181st | TG Therapeutics | $616.3m | 87.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Doximity
- How much revenue did Doximity make in fiscal 2026?
- Doximity reported revenue of $644.9m for fiscal 2026, compared with $570.4m in fiscal 2025.
- How much has the revenue of Doximity grown?
- Between fiscal 2021 and fiscal 2026 it went from $206.9m to $644.9m: 211.7% more, an average growth of 25.5% a year.
- What was the best year for revenue at Doximity?
- Of its last 6 fiscal years, fiscal 2026, with $644.9m.
- Where does Doximity rank in its sector by revenue?
- It ranks 179th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Doximity come from?
- From the annual report (Form 10-K) that Doximity files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Doximity files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021. More on Doximity: the Doximity page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.